By Kenneth Thorpe
Mar 31, 2020 1:01pm
Hospitals across the globe are overwhelmed with coronavirus patients. Many of those patients ultimately develop viral pneumonia, one of the most common symptoms.
But a subset of patients must fight another—
Proposal ultimately would drive up healthcare spending
February 27, 2020
Roughly half of sick Americans struggle to afford their prescription drugs. And a new rule from the Trump administration could soon make their lives even more difficult.
February 3, 2020 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) has released the following statement on the proposed international pricing index:
The Partnership to Fight Chronic Disease opposes proposed “international pricing index” models to address
Kenneth E. Thorpe, Guest columnist
5:00 p.m. CT Jan. 14, 2020
Quality-adjusted life year cost-benefit analyses systemically undervalue the lives of patients with disabilities.
Imagine if the federal government treated disabled Americans as second-class citizens. It's an
Congressional briefing examines how social determinants, health disparities impact America's hardest hit populations
December 12, 2019 (Washington, D.C.) Recent research data developed by IHS Markit on behalf of the Partnership to Fight Chronic Disease (PFCD) examines the enormous
Ethical questions loom over innovative efforts that can save lives
November 21, 2019 09:01 AM Eastern Standard Time
WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) has released the following statement regarding the National Council
Better overall health, reduced chronic disease rates key to lowering health spending
November 19, 2019 11:37 AM Eastern Standard Time
WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) has just released, “What Accounts for the Growth in Private Health
By Kenneth E. Thorpe
October 10, 2019
A prominent healthcare watchdog has found the solution to high drug prices – or so it claims.
For years, the nonprofit Institute for Clinical and Economic Review (ICER) has analyzed and rated the cost-
By Kenneth E. Thorpe
March 28, 2019
Every month, drug companies offer up nearly $13 billion in rebates and other discounts.
Patients don't see these savings at the drugstore, though. The supply chain all but ensures that discounts instead flow to
Widespread impact for patients, employers and health plans could also result in one million fewer hospitalizations
March 12, 2019 09:09 AM Eastern Daylight Time
WASHINGTON--(BUSINESS WIRE)--A new study released today by the Partnership to Fight Chronic Disease (